U.K. authorizes Moderna COVID-19 vaccine

By The Science Advisory Board staff writers

January 8, 2021 -- The U.K.'s Medicines and Healthcare products Regulatory Agency approved Moderna's messenger RNA (mRNA) COVID-19 vaccine, mRNA-1273, for use under Regulation 174.

The temporary authorization permits the supply of the COVID-19 vaccine in Great Britain. The U.K. government purchased an additional 10 million doses of the Moderna vaccine, bringing its confirmed order commitment to 17 million doses. The first U.K. deliveries of the vaccine will commence early this year, Moderna said.

The U.K. is the fifth jurisdiction to authorize Moderna's COVID-19 vaccine, following the U.S., Canada, Israel, and the European Union. Additional authorizations are currently under review in a number of countries such as Singapore and Switzerland, the firm said.

EC authorizes Moderna's COVID-19 vaccine
The European Commission (EC) has granted a conditional marketing authorization for Moderna's messenger RNA (mRNA) COVID-19 vaccine, mRNA-1273. The authorization...
Allergic reactions to COVID-19 vaccines shouldn't stop vaccinations
COVID-19 vaccines currently approved for emergency use by the U.S. Food and Drug Administration are safe even among people with food or medication allergies,...
FDA moves quickly toward formal Moderna EUA decision
The U.S. Food and Drug Administration (FDA) has informed Moderna that it will work rapidly toward the issuance of an emergency use authorization (EUA)...
Europe buys 80M more doses of Moderna COVID-19 vaccine
The European Commission has exercised an option to purchase an additional 80 million doses of Moderna's messenger RNA (mRNA) COVID-19 vaccine candidate,...
FDA issues EUA for Moderna COVID-19 vaccine
Just one day after a favorable committee recommendation, the U.S. Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for...

Copyright © 2021 scienceboard.net

Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter